Come up with a name for your new list and we'll add to it:
NeoClone raised a round of funding on January 12, 2013. Investors include
Wisconsin Investment Partners.
NeoClone is a custom monoclonal antibody company focused on developing high quality antibodies for sale as reagents and establishing partnerships and collaborations to develop diagnostic mAbs.…